Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Emerging Microbes & Infections|January 9, 2025
An IS element-driven antisense RNA attenuates the expression of serotype 2 fimbriae and the cytotoxicity of <i>Bordetella pertussis</i>Alexandre D'Halluin, Denisa Petráčková, Ivana Čurnová, et al.
Plos One|October 12, 2018
Distinct virulence ranges for infection of mice by Bordetella pertussis revealed by engineering of the sensor-kinase BvgSElodie Lesne, Loic Coutte, Luis Solans, et al.
The Journal of Biological Chemistry|July 24, 2015
Signal Transduction by BvgS Sensor Kinase: BINDING OF MODULATOR NICOTINATE AFFECTS THE CONFORMATION AND DYNAMICS OF THE ENTIRE PERIPLASMIC MOIETYElian Dupré, Elodie Lesne, Jérémy Guérin, et al.
Plos One|May 12, 2017
Characterization of a Bvg-regulated fatty acid methyl-transferase in Bordetella pertussisAlex Rivera-Millot, Elodie Lesne, Luis Solans, et al.
RNA Biology|April 24, 2018
Primary transcriptome analysis reveals importance of IS elements for the shaping of the transcriptional landscape of Bordetella pertussisFabian Amman, Alexandre D'Halluin, Rudy Antoine, et al.
Communications Biology|January 9, 2021
Streamlined copper defenses make Bordetella pertussis reliant on custom-made operonAlex Rivera-Millot, Stéphanie Slupek, Jonathan Chatagnon, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Alanine dependence of trans-translation contributes to riboregulation of mycobacterial antibiotic recalcitrance genesAndrea Majstorovic, Helene Botella, Sarah M Schrader, et al.
Nature Microbiology|July 23, 2021
Parallel in vivo experimental evolution reveals that increased stress resistance was key for the emergence of persistent tuberculosis bacilliAideen C Allen, Wladimir Malaga, Cyril Gaudin, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial AcidificationLéo Faïon, Kamel Djaout, Catalin Pintiala, et al.
Journal of Medicinal Chemistry|December 6, 2022
Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH DehydrogenasesSushovan Dam, Salia Tangara, Claire Hamela, et al.
Pageof 5